Poster Session A - Sunday Afternoon
Category: Biliary/Pancreas
Ahmed Eltelbany, MD, MPH
Cleveland Clinic
Cleveland, OH
Variable | Patients who received ICI | Patients with Cholangitis who did not receive ICI | |||
ICI without Cholangitis | ICI-Induced Cholangitis | ||||
Age 18 -65 >65 |
7190 (37%) 12,250 (63%) |
90 (35%) 160 (62%) |
417,140 (59%) 288,960 (41%) | ||
Female | 8,130 (42%) | 130 (50%) | 475,350 (67%) | ||
Race Caucasian Others |
16,150 (84%) 3180 (16%) |
220 (85%) 40 (15%) |
| ||
Co-morbidities Hypertension T2DM Hyperlipidemia Obesity CAD Choledocholithiasis |
19,330 (71%) 5,560 (29%) 11,830 (62%) 4,510 (23%) 5,720 (30%) 1,570 (8%) |
200 (77%) 90 (35%) 160 (62%) 90 (35%) 90 (35%) 170 (65%) |
382,890 (54%) 176,910 (25%) 329,520 (47%) 236,120 (33%) 130,060 (18%) 532,590 (75%) |